|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Pathology (Dr. Nagesh), Internal Medicine (Dr. Jindal), and Immunopathology (Drs. Sehgal and Arora), Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Correspondence to: Sunil K. Arora, PhD, Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India; e-mail sunilkarora@ glide. net.in
| Abstract |
|---|
|
|
|---|
Methods: The sensitivity and specificity of PCR in detection of mycobacterial DNA in 20 samples of tuberculous pleural effusion were evaluated using 40 samples of nontubercular pleural effusion as controls. The results were correlated with the ADA in all 60 pleural fluids. In addition, AFB detection by Ziehl-Neelsen staining on cytospin smears of all pleural fluids was also compared.
Results: Of the 20 samples of tuberculous pleural effusion, mycobacterium could be detected by AFB staining in 4 samples. Fourteen samples were PCR positive. None of the samples from the control group were AFB or PCR positive. The sensitivity of PCR, therefore, was 70.0% with specificity of 100% (positive predictive value, 100%; negative predictive value, 86.95%). The sensitivity of AFB screening was at best 20%. The mean of ADA values in tubercular pleural effusions was 63.21 U/L (SD, 33.01), and the mean in the control samples was 51.1 U/L (SD, 29.71). Taking a cut-off value of 50 U/L, both the sensitivity and specificity of ADA estimation in diagnosing tuberculosis were only 55%.
Conclusion: PCR represents a rapid and sensitive method for the detection of mycobacterial DNA in tuberculous pleural effusions. AFB screening has low sensitivity, and ADA estimation has both low sensitivity and specificity. Therefore, when the clinical suspicion is high and smear result is negative, but the signs and symptoms of M tuberculosis are apparent, PCR is the method of choice for identifying the infection.
Key Words: acid-fast bacilli adenosine deaminase activity Mycobacterium tuberculosis pleural fluids polymerase chain reaction
| Introduction |
|---|
|
|
|---|
Improved case detection and effective treatment are two of the key factors mandatory for better control of mycobacterial diseases. The laboratory diagnosis of tuberculosis is based on the traditional method of Ziehl-Neelsen acid-fast bacilli (AFB) stain and on laboratory culture of the causative organism, Mycobacterium tuberculosis. Ziehl-Neelsen stain, although rapid and inexpensive, lacks sensitivity. The culture, although sensitive (10 to 100 viable organisms per sample),1 takes a long period to complete, and clinical and therapeutic decisions have to be made before the laboratory diagnosis becomes available. Culture techniques also require viable organisms, and this is often a problem in partially treated patients. Because of the shortcomings of these traditional methods, several rapid detection methods have been developed, such as DNA probes, and the BACTEC system (Johnston Laboratories Inc; Towson, MD), etc.2 3 4 5 6 However, none of these meet the requirement of rapidity, sensitivity, and specificity, and they often require sophisticated equipment and highly trained personnel.
The polymerase chain reaction (PCR) can specifically amplify discrete fragments of DNA in which target material is present in only picogram quantities. It is now a well-developed technique and has been used extensively for the diagnosis of numerous infectious diseases.7 8 9 10 11 The major benefits of this rapid diagnostic test are improved patient care, reduced medical costs, and more effective use of isolation rooms. In this study, we have evaluated the efficacy of PCR for detection of mycobacterial DNA in pleural fluids and correlated the results with adenosine deaminase activity (ADA) values of the same pleural fluid along with a comparison to the traditional AFB screening method by Ziehl-Neelsen staining.
| Materials and Methods |
|---|
|
|
|---|
Study Design
The study was done prospectively in a blinded manner in which
the clinical diagnosis was not available to the laboratory personnel
performing the PCR. Each pleural fluid sample received in the
laboratory was divided into two parts. One part was microcentrifuged
for 20 min. The supernatant was taken for ADA estimation and the pellet
for DNA extraction. The other sample was used for cytospin smear
preparation on which Ziehl-Neelsen staining was done. ADA estimation
was done by the method of Giusti (1974).12
The final clinical diagnosis in each case was retrieved from the case files of the medical record library of our hospital only at the time of analysis of data. The results of the PCR were not known at the time of clinical assignment of cases. Subsequently, the cases were grouped under tuberculous (20 cases) and nontuberculous (40 cases) pleural effusion based on the following criteria. Cases were included in tuberculous group (Table 1 ) if (1) patients received a diagnosis of pulmonary tuberculosis made on the basis of histologic findings, such as granulomatous inflammation consistent with tuberculosis in fine-needle aspiration cytology (FNAC) material from lymph nodes or pleural biopsy; and/or (2) patients received a diagnosis of pulmonary tuberculosis made on the basis of AFB staining from sputum, BAL/FNAC/pleural fluid; and or (3) patients having a chest radiograph strongly suggestive of pulmonary tuberculosis with a therapeutic response to ATT even in absence of sputum positivity. All other cases not in the above category were grouped as nontuberculous pleural effusions, which included cases of disseminated carcinoma (n = 6), liver disease with portal hypertension (n = 6), lymphoma (n = 4), congestive cardiac failure (n = 5), systemic lupus erythematosus (n = 2), and others.
|
Primers
The primers used for the amplification of a conserved repetitive
sequence in the M tuberculosis DNA were primer I (5'
GACACCTCATCGGCACCCGC 3') and primer J (5' GCCATGCGATGTCATAAG 3'), which
amplify a specific 150-base pair (bp) product in the
PCR.14
PCR
A typical PCR reaction mixture contained 1 x PCR buffer, 1.5
mM MgCl2, 200 mM each of deoxynucleoside
triphosphates (ie, deoxyadenosine triphosphate,
deoxycitadine triphosphate, deoxyguanosine triphosphate, and
deoxythymidine triphosphate), 0.5 mM each of primer I and primer
J, and 0.5 U of Taq DNA polymerase enzyme (Boehringer
Mannheim; Mannheim, Germany). The DNA from the
clinical samples was added and volume made up with autoclaved distilled
water. Each set of PCR reactions contained a positive control
containing 1.0 pg. DNA from H37Rv strain of
M tuberculosis and two negative controls, one containing the
same amount of DNA extracted from lymphocytes of healthy individuals,
and the other containing the same amount of autoclaved water. The
thermal cycler (Model 480; Perkin-Elmer; Norwalk, CT) was programmed
for 35 cycles with initial denaturation at 94°C for 10 min,
denaturation at 94°C for 1 min, annealing at 56°C for 1 min,
extension at 72°C for 1 min, and final extension at 72°C for 10
min.
Post-PCR Detection
The contents after the PCR were once extracted with chloroform,
and the amplified product was detected by (1) gel
electrophoresis and (2) dot hybridization (Fig 1
,
2). Fifteen microliters of the amplified product was electrophoresed on
a 2% agarose gel in 0.5 x Tris-borate-EDTA buffer at a pH of 8.6.
The gel was stained with ethidium bromide (5 µg/mL), and the 150-bp
amplified band was visualized on an ultraviolet transilluminator
(Model 3-1000; Fotodyne; New Berline, WI).
|
| Results |
|---|
|
|
|---|
Of the tuberculous samples, four tested positive for AFB. In one
sample, a single AFB was detected after a long search. Considering all
the modalities of histologic diagnosis (pleural biopsy, BAL, sputum and
pleural fluid examination), a total of eight samples were AFB positive.
Thus, pleural fluid missed 50% of microscopically positive samples. Of
the 20 samples from the tuberculosis patients (study group), 14 were
PCR positive. None of the samples from the control group were AFB or
PCR positive. Therefore, the sensitivity of PCR in this study was 70%
with a specificity of 100%. The positive predictive value (PPV) was
100%, and the negative predictive value (NPV) was 86.95%. The
2 was applied, and the results showed a
p < 0.01. The sensitivity of AFB screening was at best 20% with
specificity of 100% (PPV, 100%; NPV, 71.2%). The sensitivity of AFB
screening would be much lower in the routine day-to-day screening,
since we were able to find very occasional single bacilli after
extensive search by two independent observers.
The mean of ADA values in tubercular pleural effusions was
63.21 U/L (SD, 33.01), and the mean of ADA values of control group was
51.1 U/L (SD, 29.71). To test the significance of the difference
between the study and the control groups, an unpaired t test
was applied and the result showed significance at p < 0.01. It is
clear from Table 2
that 10 patients had an ADA value of
50 U/L. Thus, taking a cut-off
value of 50 U/L, both the sensitivity and the specificity of ADA in
diagnosing tuberculosis were only 55%.
|
| Discussion |
|---|
|
|
|---|
In aspirates from tuberculous pleural effusions, organisms are rarely seen following Ziehl-Neelsen staining, and a bacterial culture finding in one study16 was positive in only 20 to 30% of patients. The fluid collects as a result of a delayed hypersensitivity reaction to tuberculous proteins.17 In our study, of a total of 20 samples, four samples showed AFB positivity, which gives a sensitivity of 20%.
Adenosine deaminase is an enzyme involved in purine catabolism found in most cells, but particularly in lymphocytes where its concentration is inversely related to the degree of differentiation. High levels of ADA were found in patients with tuberculous pleurisy. At a level of 50 U/L, the sensitivity and specificity claimed for identification of tuberculosis are 90% and 89%, respectively.18 Levels of ADA show a significant correlation with number of CD4+ lymphocytes in pleural effusion. False-positive test results are therefore found in patients with rheumatoid disease, chronic lymphatic leukemia, and undifferentiated lymphoma. Neutrophils contribute to the high level of ADA found in empyema fluid.19 Therefore, many serious doubts have been cast on the usefulness of ADA levels in the detection of tuberculous pleurisy.20 21
In our study, the mean of ADA values for tuberculous pleural effusion was 63.21 U/L (SD, 33.01) and that of nontuberculous pleural effusion was 51.1 U/L (SD, 29.71). Both sensitivity and specificity together were maximum at a cut-off value of 50 U/L and amounted to 55% each. None of our tuberculosis patients had coexisting diseases such as rheumatoid arthritis or chronic lymphatic leukemia, etc. Since the patients were randomly included in the control group, there was no bias. However, these results are in contrast to another study.20
PCR is being evaluated for diagnosis of a number of diseases, including detection of infectious agents.7 8 9 10 11 Because mycobacterial detection is hampered by the difficulties noted earlier, PCR is being widely considered as an alternative tool that is both rapid and highly sensitive. An additional advantage is its high specificity, which helps in identifying the specific mycobacterial strain.
In our study, pleural fluids were processed in batches (8 to 10 specimens) that included a DNA-free control. In order to minimize the risk of contamination with exogenous M tuberculosis DNA, these procedures were performed using disposable tubes and pipettes. In addition, a sample blank was taken through all the preparation steps to detect possible contamination. Reagents were prepared using autoclaved deionized distilled water from a laboratory in which no mycobacterial work was being done, and were autoclaved prior to use. Furthermore, pre-PCR, PCR, and post-PCR procedures were performed in different laboratories.
The results showed that mycobacterial DNA was amplified in 14 of the 20 patients with tubercular pleurisy. Although there is possibility of a false-positive PCR finding due to the presence of old healed tuberculosis infection in a patient having nontubercular effusion due to other diseases, none of the patients in our control group showed PCR positivity, showing our assay system for pleural fluids to be quite specific. Thus, PCR shows a sensitivity of 70% and specificity of 100% along with a PPV of 100%. Although an NPV of 86.95% does indicate that a negative PCR does not absolutely rule out a tuberculous infection, a positive PCR result means the patient definitely has tuberculosis. The results suggest that the PCR is more sensitive than other existing methods, but still not nearly good enough to identify all cases. The results are not surprising considering the fact that pleural effusion in patients with tuberculosis mainly occurs as a result of a delayed hypersensitivity reaction to tuberculous proteins, and the presence of bacilli in pleural fluid is not always necessary.17 All of the patients with positive PCR results had responded very well to ATT. It was shown in a previous study22 that patients with inflammatory uveitis who were treated with ATT based on a PCR test result showed resolution of inflammation with no recurrence for 2 years of follow-up.
Negative PCR results seen in six patients may be due either to inhibitors of Taq polymerase that are particularly high in pleural fluids or to sampling difficulties. The chance of detecting mycobacterium becomes higher with a bigger sample size. Since we had taken only 2 mL per patient, a small sample size may have affected the results to some degree. However, whenever the result was positive, the mycobacterial load must have been sufficiently high.
In conclusion, AFB screening is not a useful method for pleural effusions because of its low sensitivity. Considering the fact that a meticulous prolonged search was carried out in our study by two independent observers, day-to-day practice may show lower sensitivity. Estimation of ADA activity, although claimed to be a useful screening test for picking up tubercular pleural effusion cases, does not seem to reflect the same in our study. It failed to pick up 50% of the tuberculosis cases. In tuberculous pleural effusions, which are frequently due to a hypersensitivity reaction to tuberculous proteins, bacillary load may be extremely low and thus PCR is the method of choice for detecting the organism because of its high sensitivity and specificity.
|
| Footnotes |
|---|
Received for publication November 29, 1999. Accepted for publication January 24, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Gopi, S. M. Madhavan, S. K. Sharma, and S. A. Sahn Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006 Chest, March 1, 2007; 131(3): 880 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chakravorty, M. K. Sen, and J. S. Tyagi Diagnosis of Extrapulmonary Tuberculosis by Smear, Culture, and PCR Using Universal Sample Processing Technology J. Clin. Microbiol., September 1, 2005; 43(9): 4357 - 4362. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Wiener, P. Della-Latta, and N. W. Schluger Effect of Nucleic Acid Amplification for Mycobacterium tuberculosis on Clinical Decision Making in Suspected Extrapulmonary Tuberculosis Chest, July 1, 2005; 128(1): 102 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Hasaneen, M. E. Zaki, H. M. Shalaby, and A. S. El-Morsi Polymerase Chain Reaction of Pleural Biopsy Is a Rapid and Sensitive Method for the Diagnosis of Tuberculous Pleural Effusion Chest, December 1, 2003; 124(6): 2105 - 2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Lima, J. K. B. Colares, and B. A. L. da Fonseca Combined Use of the Polymerase Chain Reaction and Detection of Adenosine Deaminase Activity on Pleural Fluid Improves the Rate of Diagnosis of Pleural Tuberculosis Chest, September 1, 2003; 124(3): 909 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Falguera, A. Lopez, A. Nogues, J. M. Porcel, and M. Rubio-Caballero Evaluation of the Polymerase Chain Reaction Method for Detection of Streptococcus pneumoniae DNA in Pleural Fluid Samples Chest, December 1, 2002; 122(6): 2212 - 2216. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jimenez, G. Diaz, E. Perez-Rodriguez, and S. Arora Diagnosis of Pleural Tuberculosis Chest, March 1, 2002; 121(3): 1005 - 1005. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |